Aurinia Pharmaceuticals Inc.
AUPH
$12.27
$0.191.57%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 315.05M | 312.59M | 358.44M | 348.24M | 330.33M |
Total Receivables | 40.39M | 40.55M | 37.14M | 36.48M | 25.52M |
Inventory | 46.50M | 46.20M | 39.23M | 38.71M | 38.85M |
Prepaid Expenses | 6.58M | 5.54M | 11.22M | 9.63M | 7.84M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 453.00K | 896.00K | 566.00K | 7.40M | 7.12M |
Total Current Assets | 408.97M | 405.76M | 446.60M | 440.46M | 409.67M |
|
|||||
Total Current Assets | 408.97M | 405.76M | 446.60M | 440.46M | 409.67M |
Net Property, Plant & Equipment | 89.45M | 94.11M | 98.87M | 103.53M | 108.18M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 4.05M | 4.16M | 4.36M | 4.51M | 4.62M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 93.00K | 823.00K | 823.00K | 868.00K | 867.00K |
Total Assets | 502.56M | 504.85M | 550.65M | 549.36M | 523.53M |
|
|||||
Total Accounts Payable | 3.31M | 4.22M | 5.19M | 8.88M | 8.42M |
Total Accrued Expenses | 49.39M | 41.73M | 54.12M | 46.71M | 46.92M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 17.21M | 15.54M | 15.07M | 15.95M | 14.91M |
Total Finance Division Other Current Liabilities | 8.35M | 6.91M | 23.39M | 7.08M | 6.66M |
Total Other Current Liabilities | 8.35M | 6.91M | 23.39M | 7.08M | 6.66M |
Total Current Liabilities | 78.27M | 68.41M | 97.76M | 78.61M | 76.90M |
|
|||||
Total Current Liabilities | 78.27M | 68.41M | 97.76M | 78.61M | 76.90M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 64.62M | 62.37M | 64.30M | 71.91M | 71.07M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 24.38M | 23.89M | 11.11M | 10.84M | 10.94M |
Total Liabilities | 167.26M | 154.66M | 173.17M | 161.36M | 158.91M |
|
|||||
Common Stock & APIC | 1.23B | 1.26B | 1.31B | 1.33B | 1.32B |
Retained Earnings | -891.71M | -913.23M | -936.57M | -938.00M | -952.35M |
Treasury Stock & Other | -905.00K | -825.00K | -647.00K | -385.00K | -859.00K |
Total Common Equity | 335.30M | 350.19M | 377.48M | 388.00M | 364.62M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 335.30M | 350.19M | 377.48M | 388.00M | 364.62M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 335.30M | 350.19M | 377.48M | 388.00M | 364.62M |
|